Clinical Trial Update: Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Zileuton CR versus placebo in adults with poorly controlled asthma on moderate-dose inhaled corticosteroids was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Zileuton CR (zileuton)

Snippet

Sponsor: Critical Therapeutics | Conditions: Asthma | Phase 4 | Status: TERMINATED